Product
What if you could anticipate clinical trial outcomes months ahead of time?
STAT Trials Pulse is the most advanced early warning system for clinical trial updates, trusted by the leading hedge funds, pharmaceutical companies, and biotech firms.
TRUSTED BY
Impact
Be the first to know about important shifts in clinical trials including roadblocks, results, recruitment activity, regulatory updates, timeline delays, and more.
Customizable
Watchlists
Watchlists
Monitor updates across clinical trials registries, scientific papers, and press releases for organizations, conditions, and interventions you care about.
Smart
Alerts
Alerts
Get real-time notifications for your watchlists and followed trials, along with contextual interpretation for each new update.
Global
Trends
Trends
Discover the highest impact activity across drug development and regulatory approval processes.
Email
Briefing
Briefing
Receive a daily digest with the most important updates in your corner of the clinical trials landscape.
Coverage across 22,000 organizations, 26,000 interventions, and 5,800 diseases.
ALGORITHMS VETTED BY EXPERTS
Specialized algorithms developed to replicate the rigorous research process of biotech journalists.
Adam Feuerstein, STAT News
“STAT Trials Pulse is an essential platform for anyone who needs to find, track and analyze clinical trials.”
Kate Sheridan, STAT News
“The algorithm’s ability to surface otherwise invisible trends is truly remarkable.”
Matt Herper, STAT News
"STAT Trials Pulse provides a new way to find and track changes in the studies that matter to you."
PREPARE YOUR NEXT MOVE
Join the new establishment of data-driven life sciences professionals who see ahead of the news.
There are over 6,800 clinical trials updates every day. Trying to analyze these changes and look for outliers is a staggering undertaking — but is also essential for investment firms and pharmaceutical companies making strategic decisions.
"The platform allows us to stay on top of clinical trials while understanding what is driving various shifts so we can prepare our next moves."
Analyst, Biopharma
$25B AUM Hedge Fund
“STAT Trials Pulse stands out by its ability to surface and classify updates in trial records – not only does it tell us that something changed, it tells me exactly what that change is. ”
Director, Competitive Intelligence
Fortune 500 Pharmaceutical Company
